Navigation Links
CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug
Date:8/19/2007

as Multikine produced in the same manufacturing facility for Phase III clinical trials and the sale of the product because this arrangement helps to ensure that the drug lots used to conduct the clinical trials will be consistent with those that will be marketed subsequent to approval.

Although some biotech companies outsource their manufacturing, this can be risky with biologics because they require intense manufacturing and process control. With biologic products a minor change in manufacturing and process control can result in a major change in the final product. Good and consistent manufacturing and process control is critical and is best assured if the product is manufactured and controlled in the manufacturer's own facility by their own specially trained personnel. In fact, there have been many situations in which companies had to repeat their Phase III trials or perform an additional clinical bridging study to address regulatory concerns resulting from outsourced manufacturing. This has led to enormous costs and lengthy delays in getting biotech drugs to market. In addition, using a contract manufacturer ties the company's approval to the manufacturing facility of the contractor, further reducing the level of control by the company.

Geert Kersten, Chief Executive Officer of CEL-SCI said, "Manufacturing biologics is such an expensive endeavor that most biotech companies partner with larger companies, and in the process give up their marketing rights. The funding with BioRealty, Inc. will allow us to keep the marketing rights, thereby giving our shareholders the greatest value creation. Now that the significant hurdle of manufacturing has been tackled, we are able to focus on getting Multikine through Phase III, and ultimately to patients."

Stan Wendzel, Managing Director of BioRealty, Inc. said, "After having completed the due diligence on both CEL-SCI and its Multikine product, we recognized that CEL-SCI may fundamentally change the standard
'/>"/>

SOURCE CEL-SCI Corporation

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related medicine technology :

1. CEL-SCIS CEL-1000 Shown to Significantly Enhance Immune Response Against Avian Flu Antigen in Animals
2. CEL-SCI Presents Long-Term Cancer Survival Data With Multikine
3. CEL-SCIs Cel-1000 Shown to Significantly Enhance Immune Response Against Hepatitis B Antigen in Animals
4. Largest National U.S. Healthcare Facility MRSA Study Reveals Infection Rates Eight Times Greater Than Previous Estimates
5. Vastox Awarded £400,000 Grant to Support R&D at Carbohydrate Chemistry Facility
6. FDA Re-Inspection Results in Positive Re-Classification of Guayama Facility
7. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
8. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
9. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
10. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... 2015  Qualcomm Incorporated (NASDAQ: QCOM ) ... Inc., is collaborating with Davita Healthcare Partners ... powered by Qualcomm Life,s 2net™ Device Connectivity Platform ... care, informed interventions and better management of at-risk ... annual Connect 2015 ecosystem conference taking ...
(Date:8/31/2015)... , Aug. 31, 2015  AMRI (NASDAQ: ... announced a strategic collaboration focused on the development, ... active pharmaceutical ingredients, ("APIs"). The collaboration combines Saneca,s ... their expertise in developing and manufacturing controlled substance ... to tech transfer processes into these facilities. The ...
(Date:8/31/2015)... , August 31, 2015 ... entered into an exclusive licensing agreement for Redonyl ® ... estimated $300 million USD veterinary dermatology market, is a ... to support healthy skin in dogs and cats. Redonyl ... Italy , and has been received positively in ...
Breaking Medicine Technology:Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 2Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 3Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 4Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 5AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 2AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 3AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 4Premune Broadens Portfolio With Novel Innovet Skin Health Product 2Premune Broadens Portfolio With Novel Innovet Skin Health Product 3Premune Broadens Portfolio With Novel Innovet Skin Health Product 4
(Date:9/1/2015)... ... September 01, 2015 , ... ... men and pick-up artists about their experiences of female beauty, women’s emotions, fertility, ... including penis issues, as well as their relationships with other men, documenting how ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... sponsored an educational workshop for physician assistants (PAs) practicing in orthopedics. The workshop, ... Zeel™” was held by Dr. Erick Salado, an orthopedic surgeon at South Florida ...
(Date:8/31/2015)... TX (PRWEB) , ... September 01, 2015 , ... ... rehab professionals, today announced the release of ten hours of new premium on-demand ... Board of Certification members. , Athletic Trainers certified before 2014 must complete 50 ...
(Date:8/31/2015)... , ... August 31, 2015 , ... ... giving potential patients the resources they need to have a successful cosmetic procedure; ... certified plastic surgeons; Cosmetic Town Journal is always ready to help. , It ...
(Date:8/31/2015)... ... , ... In an article based on a reader’s question that ... of treating back pain caused by a disrupted disk by using steroids rather than ... function in patients suffering from a herniated disk, the level of pain that patients ...
Breaking Medicine News(10 mins):Health News:Female Porn Director Explains Male Insecurities about Women in a New Book 2Health News:New Hope for Patients Seeking Treatment of Osteoarthritis Knee Pain 2Health News:New Hope for Patients Seeking Treatment of Osteoarthritis Knee Pain 3Health News:Evidence Based Practice Courses: CEUs For Athletic Trainers Just Released 2Health News:Cosmetic Town: A One Stop Plastic Surgery Community 2Health News:Article on Steroid Use for Back Pain Highlights the Effectiveness of Surgery in Treating Disk Pain, says Dr. Seyed M. Rezaian 2
... Pandolfi, M.D., Ph.D., is the recipient of the 2011 ... outstanding work in the field of cancer genetics and ... new therapies for treating cancers. ,"Dr. Pandolfi,s research has ... molecular underpinnings of acute promyelocytic leukemia (APL)," said Margaret ...
... the field of biomedical research have prompted demands ... on Ethical Issues in Biomedical Engineering at Polytechnic ... will bring together biomedical engineers, clinicians, research scientists, ... the design and implementation of new policies and ...
... National Academy of Sciences Leopoldina has set up seven new ... intensively on topics of the future. The task of these ... investigate and discuss important future topics and to initiate activities ... could be short-term statements on acute issues or middle or ...
... Arthur D. Levinson, Ph.D., chairman and former CEO ... Association for Cancer Research Margaret Foti Award for Leadership ... 102nd Annual Meeting 2011, held April 2-6. ... achievements in cancer research, or in support of cancer ...
... FRIDAY, March 25 (HealthDay News) -- Teens whose mothers ... have a threefold increased risk of developing severe behavior ... University of Pittsburgh School of Medicine and Medical Center ... The mothers were evaluated when four and seven months ...
... of high-deductible health plans finds that while such plans ... to cut back on preventive health care, according to ... in the March edition of the American Journal of ... from across the United States, rese archers found that ...
Cached Medicine News:Health News:AACR recognizes the outstanding achievements of Pier Paolo Pandolfi 2Health News:AACR recognizes the outstanding achievements of Pier Paolo Pandolfi 3Health News:Updating ethical guidelines for biomedical engineering 2Health News:The German National Academy of Sciences Leopoldina sets up new standing committees 2Health News:Fifth Annual AACR Margaret Foti Award presented to Arthur D. Levinson, Ph.D. 2Health News:Fifth Annual AACR Margaret Foti Award presented to Arthur D. Levinson, Ph.D. 3Health News:Prenatal Alcohol Exposure Linked to Behavior Problems in Teens 2Health News:Largest study of high-deductible health plans finds savings, less preventive care 2Health News:Largest study of high-deductible health plans finds savings, less preventive care 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: